⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

February 21, 2024Open Access

Figure S1 from NRF2 Activation in Trp53;p16-deficient Mice Drives Oral Squamous Cell Carcinoma

Samera H. Hamad Rani S. Sellers Nathan Wamsley Paul Zolkind Travis P. Schrank Michael B. Major Bernard E. Weissman

View Full Paper

Ask AI

Bookmark

Share

Abstract

Figure S1 shows survival curves and weight loss of CP and CPN mice after treatment with tamoxifen.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hamad et al. (2024) studied this question.

synapsesocial.com/papers/68e78466b6db6435876f7b0e https://doi.org/10.1158/2767-9764.25259853.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S3 from NRF2 Activation in Trp53;p16-deficient Mice Drives Oral Squamous Cell Carcinoma2024
2Table S4 from NRF2 Activation in Trp53;p16-deficient Mice Drives Oral Squamous Cell Carcinoma2024
3Table S4 from NRF2 Activation in Trp53;p16-deficient Mice Drives Oral Squamous Cell Carcinoma2024
4Figure S2 from NRF2 Activation in Trp53;p16-deficient Mice Drives Oral Squamous Cell Carcinoma2024
5Figure S5 from NRF2 Activation in Trp53;p16-deficient Mice Drives Oral Squamous Cell Carcinoma2024